Boehringer Ingelheim and Walgreens are seeking out people who are overweight, living with obesity or have type 2 diabetes — specifically Black and Hispanic patient populations.
Federal antitrust officials have redoubled efforts to challenge what they see as improper pharma patent listings that delay the market entry of generic drugs. This week, the Federal Trade Commission ...
Japanese biotech Ono Pharmaceutical is acquiring Deciphera Pharmaceuticals for $2.4 billion. Bristol Myers Squibb agreed to a deal with Repertoire Immune Medicines in which it will pay $65 million ...
Grammy nominee and recording artist Raheem DeVaughn is working with Gilead Sciences to increase awareness of HIV preventive ...
The National Institutes of Health is the federal government’s main agency for supporting medical research. Is it barred from ...
The most popular weekly working pattern among adland employees is two days in the office with three remote, according to the ...
The National Institutes of Health is the federal government’s main agency for supporting medical research. Is it barred from ...
Building on the continued momentum behind its GLP-1 drugs, the pharma company’s parent company, Novo Holdings, announced a ...
The event, jointly staged by all three Haymarket Media marketing communications brands, is scheduled for September 19 in New ...
Stagwell kicked off 2024 with a return to growth. Organic revenue growth for Q1 was up 8% year over year to $670 million.
Ogilvy has appointed Antonis Kocheilas as global chief transformation officer. In this newly created role, Kocheilas will be ...
The proposed settlement will effectively end more than 700 lawsuits filed after the 2021 recall of millions of the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results